Theriva Biologics, Inc.TOVXNYSE
Loading
Debt to Assets Over TimeElevated
Percentile Rank93
3Y CAGR+26.8%
5Y CAGR+1.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+26.8%/yr
Annual compound
5Y CAGR
+1.1%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.04 | +13.5% |
| 2023 | 0.04 | +66.8% |
| 2022 | 0.02 | +7.8% |
| 2021 | 0.02 | -61.4% |
| 2020 | 0.06 | +34.3% |
| 2019 | 0.04 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |